These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7894388)

  • 1. Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats.
    Banerji AP; Fernandes AO
    Cell Biol Int; 1994 Nov; 18(11):1025-34. PubMed ID: 7894388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification and complex formation studies with jack bean proteinase inhibitor.
    Kumari NN; Pattabiraman TN
    Indian J Biochem Biophys; 1991; 28(5-6):425-33. PubMed ID: 1812077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S; Habs M; Reinhold H; Schmähl D
    Arzneimittelforschung; 1979; 29(3):477-9. PubMed ID: 582732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies with Proresid (SP-I) in various innoculation tumors].
    Osswald H; Schmähl D
    Med Klin; 1966 Apr; 61(17):681-4. PubMed ID: 5995181
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral blood lymphocyte nucleoli of rats with Yoshida ascitic sarcoma and the effect of cyclophosphamide.
    Matĕjková E
    Folia Biol (Praha); 1975; 21(5):349-53. PubMed ID: 1201807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine proteinase from rice bean.
    Basu PS; Biswas C; Majhi R; Datta TK
    Indian J Biochem Biophys; 1996 Dec; 33(6):491-7. PubMed ID: 9219435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Strain of Yoshida sarcoma with induced pafencil resistance].
    Khomchenovskiĭ EI; Burova GF
    Biull Eksp Biol Med; 1985 Apr; 99(4):479-81. PubMed ID: 3986376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in lysosomal enzyme activities of Yoshida sarcoma cells in rats treated with anticancer agents in relation to their therapeutic effects.
    Abe I; Sato S
    Sci Rep Res Inst Tohoku Univ Med; 1974 Dec; 21(3-4):76-86. PubMed ID: 4467316
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of the combined treatment of radiation and carcinostatic agents on Yoshida-sarcoma cells].
    Saito T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1965 Nov; 25(8):908-29. PubMed ID: 5230072
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that non-caspase proteases are required for chromatin degradation during apoptosis.
    Hughes FM; Evans-Storms RB; Cidlowski JA
    Cell Death Differ; 1998 Dec; 5(12):1017-27. PubMed ID: 9894608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a modified CMF treatment (cyclophosphamide, methotrexate and 5-fluorouracil) on hematopoietic tissues and Yoshida sarcoma in rats.
    Savovski K; Pujić N; Vranić V; Dimitrijević B
    Acta Oncol; 1994; 33(7):793-8. PubMed ID: 7993648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent and selective inhibition of membrane-type serine protease 1 by human single-chain antibodies.
    Sun J; Pons J; Craik CS
    Biochemistry; 2003 Feb; 42(4):892-900. PubMed ID: 12549907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chymase-directed serine protease inhibitor that reacts with a single 30-kDa granzyme and blocks NK-mediated cytotoxicity.
    Woodard SL; Jackson DS; Abuelyaman AS; Powers JC; Winkler U; Hudig D
    J Immunol; 1994 Dec; 153(11):5016-25. PubMed ID: 7963562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Investigation on radiosensitizing and tumor inhibiting actions of the antioxidant MTDQ (6,6'-methylen-bis/2,2,4-trimethyl-1-1,2-dihydroquinolin) (author's transl)].
    Bär V; Foris G; Erdélyi V; Pollák Z; Eckhardt S
    Arch Geschwulstforsch; 1975; 45(5):489-95. PubMed ID: 1212067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour principles from Peganum harmala seeds.
    Lamchouri F; Settaf A; Cherrah Y; Zemzami M; Lyoussi B; Zaid A; Atif N; Hassar M
    Therapie; 1999; 54(6):753-8. PubMed ID: 10709452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the combined treatment of radiation and carcinostatic agents on Yoshida sarcoma cells.
    Adachi T; Saito T
    Bull Tokyo Med Dent Univ; 1966 Dec; 13(4):445-66. PubMed ID: 5234383
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ineffectiveness of CH 23 in Yoshida sarcoma of the rat and mouse sarcoma 180].
    Schmähl D; Ballweg H; Berndt F; Osswald H
    Arzneimittelforschung; 1968 May; 18(5):588-9. PubMed ID: 5755887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.